General MedicationsVAGINALGeneric
METRONIDAZOLE
METRONIDAZOLE
Standard Dose
1.3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview METRONIDAZOLE is listed in Drugs@FDA under application 216795 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METRONIDAZOLE Form and strength GEL;VAGINAL - 1.3% Sponsor ENCUBE Submission history Latest submission status date: 2024-03-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview METRONIDAZOLE is listed in Drugs@FDA under application 216795 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METRONIDAZOLE Form and strength GEL;VAGINAL - 1.3% Sponsor ENCUBE Submission history Latest submission status date: 2024-03-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.